Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor β/Smad signaling and associates with favorable breast cancer disease outcomes

Jimin Guo(Royal Victoria Hospital), Jean‐Jacques Lebrun(McGill University)
Breast Cancer Research
December 12, 2014
Cited by 29


Related Papers